Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids
This study has been terminated.
( Repros decided to stop the study because of safety and the FDA decided to put the study on hold because of safety. )
Study NCT00785356 Information provided by Repros Therapeutics Inc.
First Received on November 3, 2008. Last Updated on February 10, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Connective Tissue Diseases
Neoplasms by Histologic Type
Neoplasms, Connective and Soft Tissue
Neoplasms, Connective Tissue
Neoplasms, Muscle Tissue
Interventions listed in this trial
Proellex 25 mg
Proellex 50 mg
Sponsors listed in this trial
Repros Therapeutics Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers